NRx Pharmaceuticals Inc (NRXPW) — Financial Flexibility Index
NRx Pharmaceuticals Inc (NRXPW) has a Financial Flexibility Index of -0.17x as of March 2026. Free cash flow of $-4.29 Million (operating CF $-4.29 Million minus capex $0.00) represents 0% of total liabilities ($25.72 Million). Check NRx Pharmaceuticals Inc (NRXPW) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
NRx Pharmaceuticals Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for NRx Pharmaceuticals Inc across 9 annual periods. For the full cash flow conversion analysis, see NRx Pharmaceuticals Inc (NRXPW) cash conversion ratio.
Annual Financial Flexibility Index for NRx Pharmaceuticals Inc (2017–2025)
Year-by-year free cash flow to debt coverage for NRx Pharmaceuticals Inc. Explore NRx Pharmaceuticals Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.49x | $-14.11 Million | $-14.11 Million | $28.89 Million | ▼ -23.4% |
| 2024 | -0.40x | $-10.64 Million | $-10.64 Million | $26.87 Million | ▲ +65.2% |
| 2023 | -1.14x | $-21.65 Million | $-21.66 Million | $19.05 Million | ▲ +47.4% |
| 2022 | -2.16x | $-39.74 Million | $-39.76 Million | $18.41 Million | ▲ +31.7% |
| 2021 | -3.16x | $-37.70 Million | $-37.70 Million | $11.92 Million | ▼ -6426.1% |
| 2020 | -0.05x | $-2.26 Million | $-2.27 Million | $46.71 Million | ▲ +84.3% |
| 2019 | -0.31x | $-792.73K | $-792.73K | $2.57 Million | ▲ +18.2% |
| 2018 | -0.38x | $-473.19K | $-473.19K | $1.26 Million | ▲ +74.2% |
| 2017 | -1.46x | $-135.81K | $-135.81K | $93.17K | — |